HIV/AIDS Drug Development
Antigene PNA targeted to proviral HIV-1 DNA inhibits viral replication
Published in Blood Weekly, August 18th, 2005
"Highly active antiretroviral therapy (HAART) is unlikely to affect reservoirs of HIV in latently infected cells. Anti-gene compounds, such as peptide nucleic acids (PNAs), which block transcriptional activity via sequence-specific invasion of double-stranded DNA may be an effective strategy to target cells harboring proviral HIV DNA," scientists in Italy report.
"Here we show that a PNA oligomer (PNA(HIV)), 15 bases in length, linked to a nuclear localization signal (NLS), substantially suppressed HIV-1 replication in chronically infected lymphocytes and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-08-18)
More Articles from Blood Weekly
- Cryopreservation
Open-freezing system allows survival of cryopreserved ovarian tissue - Hemophilia
Gene therapy induces tolerance to factor VIII inhibitors - Stem Cell Research
HSC mobilization speeds renal function recovery independent of SC contribution - Stem Cell Research
Monocyte-derived Neohepatocytes developed for autologous cell therapy - Stem Cell Transplantation
Transplant of dHGF-cultured hepatocytes prolongs survival of acute liver failure - AIDS-Related Emphysema
AIDS-related emphysema partly due to direct alveolar macrophage HIV-1 infection - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
